Synact Pharma to present at upcoming investor conference

Synact Pharma, today announces that members of its executive management team is invited to present at upcoming conference.:

ABGSC Life Science Summit, virtual
Date: 25 May 2021
Presenter: Dr. Torbjørn Bjerke, (Chairman)
Time: 09.30 CET

For further information about SynAct Pharma AB, please contact:

Jeppe Øvlesen                                                                                Thomas Jonassen

CEO, SynAct Pharma AB                                                               CSO, SynAct Pharma AB

Phone: +45 28 44 75 67                                                                  Phone: +45 40 15 66 69

Mail: joo@synactpharma.com                                                         Mail: tj@synactpharma.com

About SynAct Pharma AB

SynAct Pharma AB conducts research and development in inflammatory diseases. The company has a platform technology based on a new class of drug candidates aimed at acute deterioration in chronic inflammatory diseases with the primary purpose of stimulating natural healing mechanisms. For more information: www.synactpharma.com.